| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34bdc2761df3c82a4c340f180fda6d2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94a97066e17f3967e46103ae4d96bb36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11d05e40924c78e685d633fda269401b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f24fea469841622ad35bc633348ac1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a488fb8eead6b295cccb5c2e9d98fea6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2011-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c65d7544eb0046734579a90b191ff8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbed99a930d01cb3e9e3cf5b83f45ec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a0be50b8cada60888f3ffb1a8054d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bda5c04f97603b832be6ed2177c37ee2 |
| publicationDate |
2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012040264-A2 |
| titleOfInvention |
Diagnostic tests for immune reactivity with human endothelial cell growth factor |
| abstract |
The present invention provides for methods and compositions for identifying and detecting autoantigens. Candidate autoantigens are identified by obtaining a subject sample from which HLA-DR-presented peptides are collected and identified using mass spectometry, then synthesized and reacted with the same subject peripheral blood or effected tissue. In particular, the present invention provides for endothelial cell growth factor as a novel autoantigen biomarker for Lyme disease-associated arthritis. |
| priorityDate |
2010-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |